Ethyl (R)-()-1-Ethyl-2-pyrrolidinecarboxylate
≥99%
- Product Code: 104167
CAS:
381670-33-3
Molecular Weight: | 171.24 g./mol | Molecular Formula: | C₉H₁₇NO₂ |
---|---|---|---|
EC Number: | MDL Number: | MFCD00671533 | |
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | room temperature, dry |
Product Description:
Used as a chiral building block in the synthesis of pharmaceuticals, particularly in the production of enantiomerically pure drugs. It serves as an intermediate in the preparation of active pharmaceutical ingredients (APIs) for treatments targeting neurological disorders and cardiovascular diseases. Its chiral nature makes it valuable in asymmetric synthesis, enhancing the efficiency and selectivity of drug development processes. Additionally, it is employed in research and development for creating novel compounds with potential therapeutic applications.
Sizes / Availability / Pricing:
Size (g) | Availability | Price | Quantity |
---|---|---|---|
0.200 | 10-20 days | ฿1,026.00 |
+
-
|
1.000 | 10-20 days | ฿2,448.00 |
+
-
|
Ethyl (R)-()-1-Ethyl-2-pyrrolidinecarboxylate
Used as a chiral building block in the synthesis of pharmaceuticals, particularly in the production of enantiomerically pure drugs. It serves as an intermediate in the preparation of active pharmaceutical ingredients (APIs) for treatments targeting neurological disorders and cardiovascular diseases. Its chiral nature makes it valuable in asymmetric synthesis, enhancing the efficiency and selectivity of drug development processes. Additionally, it is employed in research and development for creating novel compounds with potential therapeutic applications.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :